US Stock MarketDetailed Quotes

RAPT RAPT Therapeutics

Watchlist
  • 3.160
  • +0.110+3.61%
Close Jul 24 16:00 ET
  • 3.090
  • -0.070-2.22%
Post 16:06 ET
110.29MMarket Cap-1025P/E (TTM)

About RAPT Therapeutics Company

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Company Profile

SymbolRAPT
Company NameRAPT Therapeutics
Listing DateOct 31, 2019
Issue Price12.00
Founded2015
CEODr. Brian Russell Wong, M.D.,PhD
MarketNASDAQ
Employees131
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address561 Eccles Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-489-9000
Websitehttp://rapt.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Brian Russell Wong, M.D.,PhD
  • President, Chief Executive Officer and Director
  • 6.59M
  • Dirk G. Brockstedt, PhD
  • Chief Scientific Officer
  • --
  • Rodney Young
  • Principal Accounting Officer, Chief Financial Officer and Secretary
  • 2.18M
  • Dr. William Ho, PhD
  • Chief Medical Officer
  • 1.90M
  • William J. Rieflin
  • Chairman of the Board
  • 300.28K
  • Dr. Wendye Robbins, M.D.
  • Independent Director
  • 265.28K
  • Linda Kozick
  • Independent Director
  • 260.78K
  • Dr. Mary Ann Gray,PhD
  • Independent Director
  • 277.78K
  • Dr. Michael F. Giordano, M.D.
  • Independent Director
  • 267.78K
  • Lori Lyons-Williams
  • Independent Director
  • 262.28K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg